Pioglitazone improves in vitro viability and function of endothelial progenitor cells from individuals with impaired glucose tolerance.

Pioglitazone improves in vitro viability and function of endothelial progenitor cells from individuals with impaired glucose tolerance.

<h4>Background</h4>Evidence suggests that the PPARγ-agonist insulin sensitizer pioglitazone, may provide potential beneficial cardiovascular (CV) effects beyond its anti-hyperglycaemic function. A reduced endothelial progenitor cell (EPC) number is associated with impaired glucose tolera...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Valentina Spigoni, Angela Picconi, Monia Cito, Valentina Ridolfi, Sabrina Bonomini, Chiara Casali, Ivana Zavaroni, Luigi Gnudi, Marco Metra, Alessandra Dei Cas
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2012
Materias:
Medicine
R
Science
Q
Acceso en línea:https://doaj.org/article/d0c2c141123543ff8cc35f48394d56ee
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Ejemplares similares